Drugs Made In America Acquisition II Corp. Unit

NASDAQ: DMIIU · Financial Services · Asset Management

PublicHQ Fort Lauderdale, FL · BrowardCIK 0002040475Reports USD

#1 of 1,011 Financial Services companies by revenue

EA Score

——

FH 56DQ —GM —SS 30

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ workforce scale, listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

$4.2M

Employees

Market cap

$706.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income$4.2M$4.2M2025

Operating income-$488.4k-$488.4k2025

Total assets$505.0M$505.0M2025

Liabilities$17.8M$17.8M2025

Equity-$17.8M-$17.8M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Drugs Made In America Acquisition II Corp. Unit earned $4.2M in FY2025 net income.

Peers · Financial Services

Donegal Group Inc.71B First Farmers Financial Corporation62C Life & Banc Split Corp.63C PRA Group, Inc.49D

Neighbors

Broward →

HEICO Corporation$4.5B84B+Element Solutions Inc$2.6B78B+Chewy, Inc.$12.6B58C VSE Corporation$1.1B68B AutoNation, Inc.$27.6B74B National Beverage Corp.$1.2B78B+

Key facts

CEORoger Bendelac

SectorFinancial Services

IndustryAsset Management

HeadquartersFort Lauderdale, FL

ExchangeNASDAQ: DMIIU

Employees2

IPO date2025-09-25

Latest filings

10-Q2026-05-14 8-K2026-04-28 10-K2026-04-15 8-K2026-04-03 8-K2026-03-17 8-K2026-03-06 8-K2026-03-06 10-Q2025-11-18

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.